Clinical Trials Directory

Trials / Completed

CompletedNCT02848729

Drug Interactions Between Morphine and Orally or IV Administered Acetaminophen

A Randomized, 2-Way, Parallel, Single-Blind Pharmacokinetic Study to Evaluate the Interaction Between Intravenous Morphine and Orally or Intravenously Administered Acetaminophen in Healthy Subjects

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Mallinckrodt · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

Morphine is the opioid used to treat pain after surgery. Acetaminophen (called APAP) can reduce the amount of opioids needed for this. The problem is that morphine slows down digestion. That can delay pain relief from APAP pills. It can even change what the body does to the drug \[pharmacokinetics (PK)\]. Some doctors have started using intravenous (IV) APAP with morphine, instead of the pills. This study will measure the PK of APAP pills and IV when used with morphine in healthy volunteers. IV APAP will likely be more effective and cause fewer side effects when used with morphine to treat pain after surgery.

Detailed description

Acetaminophen can significantly reduce the use of opioid analgesics when both are used concomitantly for treating moderate to severe pain. The use of IV acetaminophen used concomitantly with opioids has increased in practice for postsurgical pain relief over orally administered acetaminophen because it provides an immediate peak plasma concentration and is believed to provide a faster analgesic effect. Opioids used to treat pain inhibit gastrointestinal motility, including delaying gastric emptying. In patients receiving opioids the absorption of orally administered acetaminophen may be delayed and could result in gastric accumulation of acetaminophen thereby markedly changing the pharmacokinetic profile. The opioid-induced inhibition of gastrointestinal motility would not be expected to affect IV acetaminophen pharmacokinetics. Thus coadministered IV acetaminophen with opioid would yield better outcome in efficacy and reduced risk of side effects comparing with coadministration of oral acetaminophen and opioids.

Conditions

Interventions

TypeNameDescription
DRUGOral AcetaminophenAcetaminophen for oral administration (2 tablets, 500 mg/tablet)
DRUGIV AcetaminophenAcetaminophen for intravenous (IV) administration (1,000 mg/100 mL)
DRUGIV MorphineMorphine for IV administration (0.125 mg/kg)
DRUGPlacebo TabletsPlacebo tablets matching oral acetaminophen
DRUGSalineSaline placebo matching IV acetaminophen

Timeline

Start date
2016-02-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2016-07-28
Last updated
2020-02-05
Results posted
2020-01-29

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02848729. Inclusion in this directory is not an endorsement.